Return to Exhibit Hall

www.amgen.com

 

                                                                                                          

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Contact Information

Michele Richard
413.437.4213
mricha04@amgen.com

Anna Storozuk
424.422.6104
astorozu@amgen.com

 

Click HERE to speak with Michele and Anna.

Meeting password: PcCM3kURu68

Product Information

Repatha®

FOURIER Sub-analysis for Recent MI Patients.pdf